The
Notice of Health Canada's proposal to enable the use of green tea extract
(EGCG/catechins) as a supplemental ingredient in foods was published on 28
July 2022, and was open to the public for comment for 75 days. No new
scientific information that changes the outcome of the safety assessment was
submitted in response to this Notice of Proposal. Since the conclusions of
the assessment remain as described in the Notice of Proposal, Health Canada
has permitted the supplemental use of green tea extract (EGCG/catechins) by
adding the entry shown in the table to Part IV of the List of Permitted Supplemental Ingredients.
The above
modification came into force 11 January 2024, the day it was published in the
List of Permitted Supplemental Ingredients.
Health
Canada's Food and Nutrition Directorate identified that certain terms and
wording used in the green tea extract entry (Part IV: Other supplemental
ingredients, G.1) published in the French version of the List of Permitted Supplemental Ingredients
on 11 January 2024, are not an accurate translation of the English version
and do not align with French terminology in similar entries. One minor
editorial error was also identified for the vitamin A (beta-carotene,
retinol) entries. Health Canada has promptly addressed the translation
inconsistencies in French.
Health
Canada's Food and Nutrition Directorate is committed to reviewing new
scientific information on the safety in use of any permitted supplemental
ingredient, including green tea extract (EGCG/catechins). Anyone wishing to
submit an inquiry or new scientific information on the use of any permitted
supplemental ingredient may do so in writing, by regular mail or
electronically.
|